About this trial
This study aims to evaluate the screening performance of the DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS) for the early detection of spondyloarthritis in patients previously diagnosed with Inflammatory Bowel Disease (IBD).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Adult patients with inflammatory bowel disease (IBD) attending the gastroenterology and outpatient clinics at Assiut University Hospital, who will be sequentially screened for early detection of associated spondyloarthritis.
Trial design
Cohort
Prospective
Treatments tested in this trial
DETAIL .IBIS_Q . MSUS
Diagnostic testAll patients will be screened using the DETAIL and IBIS-Q questionnaires, followed by a comprehensive musculoskeletal ultrasound (MSUS) assessment.
Treatment groups
Trial outcomes
Primary outcomes
Prevalence of undiagnosed spondyloarthritis
The percentage of patients with inflammatory bowel disease (IBD) who are newly diagnosed with spondyloarthritis based on DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: